Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment Phase 3 ABTECT Trial evaluating obefazimod for moderately to severely active ulcerative colitis ("UC”) reaches 1,003 of 1,224 ...
Dr Pepper has overtaken Pepsi as the second-most popular soda in the U.S., thanks to innovative marketing, new flavors, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback